Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10160013 | Acta Biomaterialia | 2013 | 10 Pages |
Abstract
The present study aimed to develop a pre-endothelialized chitosan (CH) porous hollowed scaffold for application in spinal cord regenerative therapies. CH conduits with different degrees of acetylation (DA; 4% and 15%) were prepared, characterized (microstructure, porosity and water uptake) and functionalized with a recombinant fragment of human fibronectin (rhFNIII7-10). Immobilized rhFNIII7-10 was characterized in terms of amount (125I-radiolabelling), exposure of cell-binding domains (immunofluorescence) and ability to mediate endothelial cell (EC) adhesion and cytoskeletal rearrangement. Functionalized conduits revealed a linear increase in immobilized rhFNIII7-10 with rhFNIII7-10 concentration, and, for the same concentration, higher amounts of rhFNIII7-10 on DA 4% compared with DA 15%. Moreover, rhFNIII7-10 concentrations as low as 5 and 20 μg mlâ1 in the coupling reaction were shown to provide DA 4% and 15% scaffolds, respectively, with levels of exposed cell-binding domains exceeding those observed on the control (DA 4% scaffolds incubated in a 20 μg mlâ1 human fibronectin solution). These grafting conditions proved to be effective in mediating EC adhesion/cytoskeletal organization on CH with DA 4% and 15%, without affecting the endothelial angiogenic potential. rhFNIII7-10 grafting to CH could be a strategy of particular interest in tissue engineering applications requiring the use of endothelialized porous matrices with tunable degradation rates.
Related Topics
Physical Sciences and Engineering
Chemical Engineering
Bioengineering
Authors
I.F. Amaral, I. Neiva, F. Ferreira da Silva, S.R. Sousa, A.M. Piloto, C.D.F. Lopes, M.A. Barbosa, C.J. Kirkpatrick, A.P. Pêgo,